| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.089 | 0.2 |